Litigation Details for ASTELLAS PHARMA INC. v. SANDOZ, INC. (D.N.J. 2023)
✉ Email this page to a colleague
ASTELLAS PHARMA INC. v. SANDOZ, INC. (D.N.J. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-03-02 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
| Jury Demand | None | Referred To | Jessica S. Allen |
| Patents | 8,283,380 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTELLAS PHARMA INC. v. SANDOZ, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ASTELLAS PHARMA INC. v. SANDOZ, INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-12-18 | 70 | Statement | EXHIBIT A: INITIAL CLAIM CHART FOR U.S. PATENT NO. 8,283,380 Additional Evidence: …regarding U.S. Patent No. 10,786,500 (the “’500 patent”) (the “Asserted Patent” or “Patent-in-Suit”). … ’500 Patent and its file history generally, including but ’500 Patent generally, including…claims 1-11 and the ’500 Patent’s file history 1-6); 17:49-55. ’500 Patent file history generally, …WHICH THE PARTIES AGREE Pursuant to Local Patent Rule 4.3(a), the parties identify the following | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
